Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brexit: What Now For Device Notified Bodies, CE Marks And The Future MDR/IVDR?

This article was originally published in SRA

Executive Summary

While the UK and the EU struggle to comprehend the full implications of the UK's decision to leave the EU, Amanda Maxwell considers the implications for the implementation of the future EU regulations on medical devices and IVDs, including the question mark that hangs over the future of UK notified bodies.

You may also be interested in...



Is The UK Still Open For Medtech Innovation And Reimbursement?

Confusing and ineffective channels of innovation adoption and a lack of funding hamper the UK's reputation as one of the world's health care capitals and a driver of care excellence – in spite of its global brands, NICE, MHRA and the NHS itself. But changes that should transform market access are in place and are worthy of close attention in the next two to three years.

Q&A With Nadim Yared: AdvaMed's Next Chair On Capital Formation And Global Challenges

Nadim Yared is set to become the first small-company CEO ever to chair AdvaMed's board of directors in March. The CVRx executive spoke to Medtech Insight about what that means, the challenge of raising funds in medtech, and AdvaMed's role in the current political environment in the US and abroad.

Swiss Medtech Voices Brexit Business Fears, Prepares For EU Regs

Switzerland is small in geographic terms, but a major player in medtech. It has been among the first to detail its economic concerns tied to the UK's plans to leave the European Union.

Latest News
See All
UsernamePublicRestriction

Register

MT040830

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel